Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.

Liang R, Zhang R, Li X, Wang A, Chen D, Sun K, Liu W, Li Y.

Eur J Pharm Sci. 2013 Nov 20;50(3-4):502-10. doi: 10.1016/j.ejps.2013.08.014. Epub 2013 Aug 29.

PMID:
23994054
2.

Effect of water on exenatide acylation in poly(lactide-co-glycolide) microspheres.

Liang R, Li X, Shi Y, Wang A, Sun K, Liu W, Li Y.

Int J Pharm. 2013 Sep 15;454(1):344-53. doi: 10.1016/j.ijpharm.2013.07.012. Epub 2013 Jul 16.

PMID:
23872225
3.

Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.

Dong WY, Körber M, López Esguerra V, Bodmeier R.

J Control Release. 2006 Oct 10;115(2):158-67. Epub 2006 Jul 20.

PMID:
16963145
4.
5.

Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.

Unger F, Wittmar M, Morell F, Kissel T.

Biomaterials. 2008 May;29(13):2007-14. doi: 10.1016/j.biomaterials.2007.12.027. Epub 2008 Feb 11.

PMID:
18262641
7.

Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability.

Schoenhammer K, Petersen H, Guethlein F, Goepferich A.

Int J Pharm. 2009 Apr 17;371(1-2):33-9. doi: 10.1016/j.ijpharm.2008.12.019. Epub 2008 Dec 24.

PMID:
19135512
8.

A novel in vitro release technique for peptide containing biodegradable microspheres.

Kostanski JW, DeLuca PP.

AAPS PharmSciTech. 2000 Mar 9;1(1):E4.

10.
11.

Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.

Luan X, Bodmeier R.

J Control Release. 2006 Jan 10;110(2):266-72. Epub 2005 Nov 21.

PMID:
16300851
13.
14.

Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.

Elkheshen SA, Radwan MA.

J Microencapsul. 2000 Jul-Aug;17(4):425-35.

PMID:
10898083
15.

Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.

McCarron PA, Marouf WM, Donnelly RF, Scott C.

J Biomed Mater Res A. 2008 Dec 15;87(4):873-84. doi: 10.1002/jbm.a.31835.

PMID:
18228271
16.
17.

Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release.

Park W, Na K.

Colloids Surf B Biointerfaces. 2009 Sep 1;72(2):193-200. doi: 10.1016/j.colsurfb.2009.04.002. Epub 2009 Apr 10.

PMID:
19414243
18.
19.

[Preparation and in-vitro degradation of polylactide and poly(L-lactide-co-glycolide)].

Wei Z, Liu L, Zhang M, Yang F, Qi M.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008 Feb;25(1):122-6. Chinese.

PMID:
18435272
20.

Influence of ultrasonic processing on the macromolecular properties of poly (D,L-lactide-co-glycolide) alone and in its biocomposite with hydroxyapatite.

Vukomanović M, Mitrić M, Skapin SD, Zagar E, Plavec J, Ignjatović N, Uskoković D.

Ultrason Sonochem. 2010 Jun;17(5):902-8. doi: 10.1016/j.ultsonch.2010.01.007. Epub 2010 Jan 28.

PMID:
20163978

Supplemental Content

Support Center